LONDON, April 20, 2016 /PRNewswire/ -- The latest research, 'The US Osteoarthritis Market and Competitive Landscape Insights - 2016', provides the US osteoarthritis market analysis, competitive landscape, and osteoarthritis drug sales forecast in the US.
The research includes the US osteoarthritis market size estimates for 2014, market share forecast for six years to 2020, osteoarthritis drugs market share, osteoarthritis drugs sales estimates, osteoarthritis drugs sales forecast, and osteoarthritis late stage pipeline products.
This research helps executives track competitor drugs sales and market share in the US osteoarthritis market. It supports decision making in R&D to long term marketing strategies. The report can be used for evaluating business opportunities, formulating business development strategies, and product positioning in the US osteoarthritis market.
SCOPE OF THE REPORT
- What are the drugs marketed in the US for treating osteoarthritis?
Identify drugs marketed in the US for treating osteoarthritis including brand name, molecule name, and company.
- How big is the US osteoarthritis market?
Find out estimates for the US osteoarthritis market size in 2014, key products and their sales, and how the market and products advanced from 2011. You will benefit from our accurate country and indication level valuation of products and the market.
- What is my competitor's drugs market share in the US osteoarthritis market?
You will know the market share of leading osteoarthritis brands in the US, including generics share.
- What are the key molecules in pipeline for osteoarthritis?
Find out pipeline products in clinical trial phase 3 and phase 2 for the treatment of osteoarthritis. Our coverage includes molecule, mechanism of action, and the company.
- What is the future of the US osteoarthritis market?
Gain insights into how the US osteoarthritis market will advance along with market forecast till 2020.
- Future osteoarthritis drugs forecast in the US
Find out how osteoarthritis drugs will be positioned in the US in 2020, with drug sales forecast and drug market share analysis for both marketed products and pipeline products.
Highlights of the Research:
- Marketed Osteoarthritis Drugs in the US
- The US Osteoarthritis Market Analysis
- Osteoarthritis Drugs Sales Analysis in the US
- Competitive Landscape in the US Osteoarthritis market
- Osteoarthritis Late Stage Pipeline
- The US Osteoarthritis Market Forecast
- Osteoarthritis Drugs Sales Forecast in the US
- Future Competitive Landscape
Download the full report: https://www.reportbuyer.com/product/3765529/
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers
For more information:
Research Advisor at Reportbuyer.com
Tel: +44 208 816 85 48